Global Sickle Cell Disease Treatments Market Size, Status and Forecast 2021-2027

SKU ID :QYR-17254721 | Published Date: 25-Jan-2021 | No. of pages: 99
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Sickle Cell Disease Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Infection Prevention with Vaccination and Antibiotics 1.2.3 Blood Transfusion 1.2.4 The Medication Hydroxycarbamide 1.2.5 A Transplant of Bone Marrow Cells 1.3 Market by Application 1.3.1 Global Sickle Cell Disease Treatments Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Clinics 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Sickle Cell Disease Treatments Market Perspective (2016-2027) 2.2 Sickle Cell Disease Treatments Growth Trends by Regions 2.2.1 Sickle Cell Disease Treatments Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Sickle Cell Disease Treatments Historic Market Share by Regions (2016-2021) 2.2.3 Sickle Cell Disease Treatments Forecasted Market Size by Regions (2022-2027) 2.3 Sickle Cell Disease Treatments Industry Dynamic 2.3.1 Sickle Cell Disease Treatments Market Trends 2.3.2 Sickle Cell Disease Treatments Market Drivers 2.3.3 Sickle Cell Disease Treatments Market Challenges 2.3.4 Sickle Cell Disease Treatments Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Sickle Cell Disease Treatments Players by Revenue 3.1.1 Global Top Sickle Cell Disease Treatments Players by Revenue (2016-2021) 3.1.2 Global Sickle Cell Disease Treatments Revenue Market Share by Players (2016-2021) 3.2 Global Sickle Cell Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Sickle Cell Disease Treatments Revenue 3.4 Global Sickle Cell Disease Treatments Market Concentration Ratio 3.4.1 Global Sickle Cell Disease Treatments Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatments Revenue in 2020 3.5 Sickle Cell Disease Treatments Key Players Head office and Area Served 3.6 Key Players Sickle Cell Disease Treatments Product Solution and Service 3.7 Date of Enter into Sickle Cell Disease Treatments Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Sickle Cell Disease Treatments Breakdown Data by Type 4.1 Global Sickle Cell Disease Treatments Historic Market Size by Type (2016-2021) 4.2 Global Sickle Cell Disease Treatments Forecasted Market Size by Type (2022-2027) 5 Sickle Cell Disease Treatments Breakdown Data by Application 5.1 Global Sickle Cell Disease Treatments Historic Market Size by Application (2016-2021) 5.2 Global Sickle Cell Disease Treatments Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Sickle Cell Disease Treatments Market Size (2016-2027) 6.2 North America Sickle Cell Disease Treatments Market Size by Type 6.2.1 North America Sickle Cell Disease Treatments Market Size by Type (2016-2021) 6.2.2 North America Sickle Cell Disease Treatments Market Size by Type (2022-2027) 6.2.3 North America Sickle Cell Disease Treatments Market Size by Type (2016-2027) 6.3 North America Sickle Cell Disease Treatments Market Size by Application 6.3.1 North America Sickle Cell Disease Treatments Market Size by Application (2016-2021) 6.3.2 North America Sickle Cell Disease Treatments Market Size by Application (2022-2027) 6.3.3 North America Sickle Cell Disease Treatments Market Size by Application (2016-2027) 6.4 North America Sickle Cell Disease Treatments Market Size by Country 6.4.1 North America Sickle Cell Disease Treatments Market Size by Country (2016-2021) 6.4.2 North America Sickle Cell Disease Treatments Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Sickle Cell Disease Treatments Market Size (2016-2027) 7.2 Europe Sickle Cell Disease Treatments Market Size by Type 7.2.1 Europe Sickle Cell Disease Treatments Market Size by Type (2016-2021) 7.2.2 Europe Sickle Cell Disease Treatments Market Size by Type (2022-2027) 7.2.3 Europe Sickle Cell Disease Treatments Market Size by Type (2016-2027) 7.3 Europe Sickle Cell Disease Treatments Market Size by Application 7.3.1 Europe Sickle Cell Disease Treatments Market Size by Application (2016-2021) 7.3.2 Europe Sickle Cell Disease Treatments Market Size by Application (2022-2027) 7.3.3 Europe Sickle Cell Disease Treatments Market Size by Application (2016-2027) 7.4 Europe Sickle Cell Disease Treatments Market Size by Country 7.4.1 Europe Sickle Cell Disease Treatments Market Size by Country (2016-2021) 7.4.2 Europe Sickle Cell Disease Treatments Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Sickle Cell Disease Treatments Market Size (2016-2027) 8.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type 8.2.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2016-2027) 8.3 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application 8.3.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2016-2027) 8.4 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region 8.4.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Sickle Cell Disease Treatments Market Size (2016-2027) 9.2 Latin America Sickle Cell Disease Treatments Market Size by Type 9.2.1 Latin America Sickle Cell Disease Treatments Market Size by Type (2016-2021) 9.2.2 Latin America Sickle Cell Disease Treatments Market Size by Type (2022-2027) 9.2.3 Latin America Sickle Cell Disease Treatments Market Size by Type (2016-2027) 9.3 Latin America Sickle Cell Disease Treatments Market Size by Application 9.3.1 Latin America Sickle Cell Disease Treatments Market Size by Application (2016-2021) 9.3.2 Latin America Sickle Cell Disease Treatments Market Size by Application (2022-2027) 9.3.3 Latin America Sickle Cell Disease Treatments Market Size by Application (2016-2027) 9.4 Latin America Sickle Cell Disease Treatments Market Size by Country 9.4.1 Latin America Sickle Cell Disease Treatments Market Size by Country (2016-2021) 9.4.2 Latin America Sickle Cell Disease Treatments Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Sickle Cell Disease Treatments Market Size (2016-2027) 10.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type 10.2.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2016-2027) 10.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application 10.3.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2016-2027) 10.4 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country 10.4.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 AstraZeneca Business Overview 11.1.3 AstraZeneca Sickle Cell Disease Treatments Introduction 11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.1.5 AstraZeneca Recent Development 11.2 Eli Lilly 11.2.1 Eli Lilly Company Details 11.2.2 Eli Lilly Business Overview 11.2.3 Eli Lilly Sickle Cell Disease Treatments Introduction 11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.2.5 Eli Lilly Recent Development 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Company Details 11.3.2 Bristol-Myers Squibb Business Overview 11.3.3 Bristol-Myers Squibb Sickle Cell Disease Treatments Introduction 11.3.4 Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.3.5 Bristol-Myers Squibb Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Sickle Cell Disease Treatments Introduction 11.4.4 Novartis Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Sickle Cell Disease Treatments Introduction 11.5.4 Pfizer Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Baxter 11.6.1 Baxter Company Details 11.6.2 Baxter Business Overview 11.6.3 Baxter Sickle Cell Disease Treatments Introduction 11.6.4 Baxter Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.6.5 Baxter Recent Development 11.7 Emmaus Life Sciences 11.7.1 Emmaus Life Sciences Company Details 11.7.2 Emmaus Life Sciences Business Overview 11.7.3 Emmaus Life Sciences Sickle Cell Disease Treatments Introduction 11.7.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.7.5 Emmaus Life Sciences Recent Development 11.8 Bluebird Bio 11.8.1 Bluebird Bio Company Details 11.8.2 Bluebird Bio Business Overview 11.8.3 Bluebird Bio Sickle Cell Disease Treatments Introduction 11.8.4 Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.8.5 Bluebird Bio Recent Development 11.9 Global Blood Therapeutics 11.9.1 Global Blood Therapeutics Company Details 11.9.2 Global Blood Therapeutics Business Overview 11.9.3 Global Blood Therapeutics Sickle Cell Disease Treatments Introduction 11.9.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.9.5 Global Blood Therapeutics Recent Development 11.10 Sangamo Therapeutics 11.10.1 Sangamo Therapeutics Company Details 11.10.2 Sangamo Therapeutics Business Overview 11.10.3 Sangamo Therapeutics Sickle Cell Disease Treatments Introduction 11.10.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.10.5 Sangamo Therapeutics Recent Development 11.11 Acceleron Pharma 11.11.1 Acceleron Pharma Company Details 11.11.2 Acceleron Pharma Business Overview 11.11.3 Acceleron Pharma Sickle Cell Disease Treatments Introduction 11.11.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.11.5 Acceleron Pharma Recent Development 11.12 Arena Pharmaceuticals 11.12.1 Arena Pharmaceuticals Company Details 11.12.2 Arena Pharmaceuticals Business Overview 11.12.3 Arena Pharmaceuticals Sickle Cell Disease Treatments Introduction 11.12.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.12.5 Arena Pharmaceuticals Recent Development 11.13 Alnylam Pharmaceuticals 11.13.1 Alnylam Pharmaceuticals Company Details 11.13.2 Alnylam Pharmaceuticals Business Overview 11.13.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatments Introduction 11.13.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2016-2021) 11.13.5 Alnylam Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Sickle Cell Disease Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Infection Prevention with Vaccination and Antibiotics Table 3. Key Players of Blood Transfusion Table 4. Key Players of The Medication Hydroxycarbamide Table 5. Key Players of A Transplant of Bone Marrow Cells Table 6. Global Sickle Cell Disease Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Sickle Cell Disease Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Sickle Cell Disease Treatments Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Sickle Cell Disease Treatments Market Share by Regions (2016-2021) Table 10. Global Sickle Cell Disease Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Sickle Cell Disease Treatments Market Share by Regions (2022-2027) Table 12. Sickle Cell Disease Treatments Market Trends Table 13. Sickle Cell Disease Treatments Market Drivers Table 14. Sickle Cell Disease Treatments Market Challenges Table 15. Sickle Cell Disease Treatments Market Restraints Table 16. Global Sickle Cell Disease Treatments Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Sickle Cell Disease Treatments Market Share by Players (2016-2021) Table 18. Global Top Sickle Cell Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatments as of 2020) Table 19. Ranking of Global Top Sickle Cell Disease Treatments Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Sickle Cell Disease Treatments Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Sickle Cell Disease Treatments Product Solution and Service Table 23. Date of Enter into Sickle Cell Disease Treatments Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 26. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2016-2021) Table 27. Global Sickle Cell Disease Treatments Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Sickle Cell Disease Treatments Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Sickle Cell Disease Treatments Revenue Market Share by Application (2016-2021) Table 31. Global Sickle Cell Disease Treatments Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Sickle Cell Disease Treatments Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 34. North America Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 36. North America Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Sickle Cell Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Sickle Cell Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Sickle Cell Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Sickle Cell Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Sickle Cell Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Sickle Cell Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 63. AstraZeneca Company Details Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Sickle Cell Disease Treatments Product Table 66. AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 67. AstraZeneca Recent Development Table 68. Eli Lilly Company Details Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Sickle Cell Disease Treatments Product Table 71. Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 72. Eli Lilly Recent Development Table 73. Bristol-Myers Squibb Company Details Table 74. Bristol-Myers Squibb Business Overview Table 75. Bristol-Myers Squibb Sickle Cell Disease Treatments Product Table 76. Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 77. Bristol-Myers Squibb Recent Development Table 78. Novartis Company Details Table 79. Novartis Business Overview Table 80. Novartis Sickle Cell Disease Treatments Product Table 81. Novartis Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 82. Novartis Recent Development Table 83. Pfizer Company Details Table 84. Pfizer Business Overview Table 85. Pfizer Sickle Cell Disease Treatments Product Table 86. Pfizer Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 87. Pfizer Recent Development Table 88. Baxter Company Details Table 89. Baxter Business Overview Table 90. Baxter Sickle Cell Disease Treatments Product Table 91. Baxter Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 92. Baxter Recent Development Table 93. Emmaus Life Sciences Company Details Table 94. Emmaus Life Sciences Business Overview Table 95. Emmaus Life Sciences Sickle Cell Disease Treatments Product Table 96. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 97. Emmaus Life Sciences Recent Development Table 98. Bluebird Bio Company Details Table 99. Bluebird Bio Business Overview Table 100. Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 101. Bluebird Bio Recent Development Table 102. Global Blood Therapeutics Company Details Table 103. Global Blood Therapeutics Business Overview Table 104. Global Blood Therapeutics Sickle Cell Disease Treatments Product Table 105. Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 106. Global Blood Therapeutics Recent Development Table 107. Sangamo Therapeutics Company Details Table 108. Sangamo Therapeutics Business Overview Table 109. Sangamo Therapeutics Sickle Cell Disease Treatments Product Table 110. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 111. Sangamo Therapeutics Recent Development Table 112. Acceleron Pharma Company Details Table 113. Acceleron Pharma Business Overview Table 114. Acceleron Pharma Sickle Cell Disease Treatments Product Table 115. Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 116. Acceleron Pharma Recent Development Table 117. Arena Pharmaceuticals Company Details Table 118. Arena Pharmaceuticals Business Overview Table 119. Arena Pharmaceuticals Sickle Cell Disease Treatments Product Table 120. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 121. Arena Pharmaceuticals Recent Development Table 122. Alnylam Pharmaceuticals Company Details Table 123. Alnylam Pharmaceuticals Business Overview Table 124. Alnylam Pharmaceuticals Sickle Cell Disease Treatments Product Table 125. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million) Table 126. Alnylam Pharmaceuticals Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Sickle Cell Disease Treatments Market Share by Type: 2020 VS 2027 Figure 2. Infection Prevention with Vaccination and Antibiotics Features Figure 3. Blood Transfusion Features Figure 4. The Medication Hydroxycarbamide Features Figure 5. A Transplant of Bone Marrow Cells Features Figure 6. Global Sickle Cell Disease Treatments Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Clinics Case Studies Figure 10. Others Case Studies Figure 11. Sickle Cell Disease Treatments Report Years Considered Figure 12. Global Sickle Cell Disease Treatments Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Sickle Cell Disease Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Sickle Cell Disease Treatments Market Share by Regions: 2020 VS 2027 Figure 15. Global Sickle Cell Disease Treatments Market Share by Regions (2022-2027) Figure 16. Global Sickle Cell Disease Treatments Market Share by Players in 2020 Figure 17. Global Top Sickle Cell Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatments as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatments Revenue in 2020 Figure 19. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2016-2021) Figure 20. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2022-2027) Figure 21. North America Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Sickle Cell Disease Treatments Market Share by Type (2016-2027) Figure 23. North America Sickle Cell Disease Treatments Market Share by Application (2016-2027) Figure 24. North America Sickle Cell Disease Treatments Market Share by Country (2016-2027) Figure 25. United States Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Sickle Cell Disease Treatments Market Share by Type (2016-2027) Figure 29. Europe Sickle Cell Disease Treatments Market Share by Application (2016-2027) Figure 30. Europe Sickle Cell Disease Treatments Market Share by Country (2016-2027) Figure 31. Germany Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Sickle Cell Disease Treatments Market Share by Type (2016-2027) Figure 39. Asia-Pacific Sickle Cell Disease Treatments Market Share by Application (2016-2027) Figure 40. Asia-Pacific Sickle Cell Disease Treatments Market Share by Region (2016-2027) Figure 41. China Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Sickle Cell Disease Treatments Market Share by Type (2016-2027) Figure 49. Latin America Sickle Cell Disease Treatments Market Share by Application (2016-2027) Figure 50. Latin America Sickle Cell Disease Treatments Market Share by Country (2016-2027) Figure 51. Mexico Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Sickle Cell Disease Treatments Market Share by Type (2016-2027) Figure 55. Middle East & Africa Sickle Cell Disease Treatments Market Share by Application (2016-2027) Figure 56. Middle East & Africa Sickle Cell Disease Treatments Market Share by Country (2016-2027) Figure 57. Turkey Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 61. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 64. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 65. Baxter Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 66. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 67. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 68. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 69. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 70. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 71. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 72. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed
AstraZeneca Eli Lilly Bristol-Myers Squibb Novartis Pfizer Baxter Emmaus Life Sciences Bluebird Bio Global Blood Therapeutics Sangamo Therapeutics Acceleron Pharma Arena Pharmaceuticals Alnylam Pharmaceuticals
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients